E
Eddy Cotte
Researcher at Claude Bernard University Lyon 1
Publications - 96
Citations - 2881
Eddy Cotte is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Medicine & Hyperthermic intraperitoneal chemotherapy. The author has an hindex of 24, co-authored 79 publications receiving 2309 citations.
Papers
More filters
Journal ArticleDOI
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen,François Noël Gilly,Catherine Arvieux,Eddy Cotte,Florent Boutitie,Baudouin Mansvelt,Jean Marc Bereder,Gérard Lorimier,François Quenet,Dominique Elias +9 more
TL;DR: The therapeutic approach combining cytoreductive surgery with PIC for patients with gastric carcinomatosis may achieve long-term survival in a selected group of patients (limited and resectable PC).
Journal ArticleDOI
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6).
Jérémie H. Lefevre,Laurent Mineur,Salma Kotti,Eric Rullier,Philippe Rouanet,Cécile de Chaisemartin,Bernard Meunier,Jafari Mehrdad,Eddy Cotte,Jérôme Desramé,Mehdi Karoui,Stéphane Benoist,Sylvain Kirzin,Anne Berger,Yves Panis,Guillaume Piessen,Alain Saudemont,Michel Prudhomme,Frédérique Peschaud,Anne Dubois,Jérôme Loriau,Jean-Jacques Tuech,Guillaume Meurette,Renato Lupinacci,Nicolas Goasgen,Yann Parc,Tabassome Simon,Emmanuel Tiret +27 more
TL;DR: Waiting 11 weeks after RCT did not increase the rate of pCR after surgical resection, and a longer waiting period may be associated with higher morbidity and more difficult surgical resections.
Journal ArticleDOI
Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Chemoresistant and Recurrent Advanced Epithelial Ovarian Cancer: Prospective Study of 81 Patients
Eddy Cotte,Olivier Glehen,Faheez Mohamed,Franck Lamy,Claire Falandry,François Golfier,François Noël Gilly +6 more
TL;DR: Salvage therapy combining optimal cytoreductive surgery and HIPEC may achieve long-term survival in selected patients with recurrent or chemoresistant ovarian cancer and may be most effective in patients with limited carcinomatosis or when cytoreduction surgery provides sufficient downstaging.
Journal ArticleDOI
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
Mathurin Fumery,Philippe Seksik,Philippe Seksik,Claire Auzolle,Nicolas Munoz-Bongrand,Jean-Marc Gornet,Gilles Boschetti,Eddy Cotte,Anthony Buisson,Anne Dubois,Benjamin Pariente,Philippe Zerbib,Najim Chafai,Carmen Stefanescu,Yves Panis,Philippe Marteau,Karine Pautrat,Charles Sabbagh,Jérôme Filippi,Marc Chevrier,Pascal Houzé,Xavier Jouven,Xavier Treton,Matthieu Allez +23 more
TL;DR: In this large, nationwide, prospective cohort of Crohn’s disease patients, postoperative complications were observed after 21% of the ileocecal resections, and corticosteroid treatment in the 4 weeks before surgery was significantly associated with an elevated postoperative complication rate.
Journal ArticleDOI
To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized Trial.
Quentin Denost,Philippe Rouanet,Jean-Luc Faucheron,Yves Panis,Bernard Meunier,Eddy Cotte,Guillaume Meurette,Sylvain Kirzin,Charles Sabbagh,Jérôme Loriau,Stéphane Benoist,Christophe Mariette,Igor Sielezneff,Bernard Lelong,François Mauvais,Benoit Romain,Marie-Line Barussaud,Christine Germain,Marie-Quitterie Picat,Eric Rullier,Christophe Laurent +20 more
TL;DR: This randomized trial suggests that the use of a pelvic drain after rectal excision for rectal cancer did not confer any benefit to the patient.